Skip Page Header

Home > Report to the National Advisory Committee on Drugs on "use of naloxone in the management of opiate dependence syndrome".

National Medicines Information Centre. (2002) Report to the National Advisory Committee on Drugs on "use of naloxone in the management of opiate dependence syndrome". Dublin: Stationery Office.

[img]
Preview
PDF (Use of naloxone in the management of opiate dependence syndrome) - Published Version
658kB
[img]
Preview
PDF (Summary of the use of naloxone) - Supplemental Material
54kB

This review attempts to assess the potential usefulness of naloxone as a treatment option for opiate dependency. Naloxone has been used for years as an emergency room treatment for the management of opiate overdose. It has also been used to effect rapid opiate withdrawal, however its benefits have not been compares with those from standard withdrawal regimens. A combination of buprenorphine and naloxone has recently been used and has been shown to be effective as a maintenance treatment with the naloxone reducing the risk of buprenorphine misuse. The review suggests that the data on naloxone safety and its potential uses are limited, but that preliminary results suggest that it may be useful. Further research and information are needed before its use as an emergency treatment in the community setting are needed before any such programme could be enacted.


Item Type
Report
Publication Type
Irish-related, Report
Drug Type
Opioid
Intervention Type
Harm reduction
Date
2002
Call No
REF, NACD
Pages
32 p.
Publisher
Stationery Office
Corporate Creators
National Medicines Information Centre
Place of Publication
Dublin
ISBN
0-7557-1785-6
Notes
Contains bibliograhic references, tables and questionnaire.
EndNote
Accession Number
HRB 2172 (Available), HRB 2171 (Available)

Repository Staff Only: item control page